News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Surgery, but not chemo, may benefit patients with rare ovarian neoplasms
05 May 2023
byAudrey Abella
Good quality surgery conferred a progression-free survival (PFS) benefit for women with ovarian sex cord stromal tumours (SCST) in the first-line setting and on first and second relapse. Chemotherapy, on the other hand, had no impact on survival in the first-line or relapse setting.
05 May 2023








